Skip to main content
Clinical Trials/NL-OMON42831
NL-OMON42831
Not Yet Recruiting
N/A

St. Jude Medical HeartMate® PHP CE Mark Post Approval Study - PHP PAS

St. Jude Medical0 sites15 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
St. Jude Medical
Enrollment
15
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* At least 18 years of age.
  • \* Patient presents with a non\-emergent need for complex PCI and in the opinion of the investigator is a risk of hemodynamic compromise during PCI.
  • \* Written, signed, and dated informed consent

Exclusion Criteria

  • \*Emergent PCI
  • \*ST elevation myocardial infarction within 7 days of procedure
  • \*Cardiac arrest within 7 days of procedure requiring CPR or defibrillation
  • \*Hemodynamic support with the HeartMate PHP post\-PCI is anticipated
  • \*Cardiogenic shock (SBP \<90 mmHg for \>1 hour with either cool clammy skin OR oliguria OR altered sensorium OR cardiac index \<2\.2 L/min/m2\)
  • \*Mural thrombus in the left ventricle
  • \*History of aortic valve replacement
  • \*Documented presence of aortic stenosis (orifice area of 1\.5cm2 or less)
  • \*Moderate to severe aortic insufficiency (echocardiographic assessment of aortic insufficiency graded as 2 or higher)
  • \*Severe peripheral vascular disease

Outcomes

Primary Outcomes

Not specified

Similar Trials